HomeBristol Myers Squibb’s

Bristol Myers Squibb’s

Bristol Myers Squibb stock and SPPI increase on FDA approvals, CLVS increases by 15%, and TWTR decreases on the Musk saga

Bristol Myers Squibb stock and SPPI increase on FDA approvals, CLVS increases by 15%, and TWTR decreases on the Musk saga

September 14, 2022